Melanoma
Feature
Maintaining cancer care in the face of COVID-19
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect...
Commentary
Perspective from the heartland: Cancer care and research during a public health crisis
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Feature
How is oncology adapting to COVID-19?
Feature
Disruptions in cancer care in the era of COVID-19
From the Journals
New melanoma treatments linked to mortality decline
Melanoma incidence in the U.S. has continued to rise, but BRAF inhibitors and immune checkpoint inhibitors are extending survival, data suggest....
From the Journals
Teledermoscopy using smartphones fails to boost skin cancer detection
From the Journals
Patients accept artificial intelligence in skin cancer screening
Although patient and clinician artificial intelligence tools were acceptable to most patients surveyed, 94% emphasized the importance of a human...
Conference Coverage
Largest meeting on cancer research canceled: AACR
Conference Coverage
Data overwhelmingly support use of dermoscopy in practice
LAHAINA, HAWAII – At clinics where dermoscopy is used, “two-thirds of the melanomas being detected now lack the classic ABCD features of melanoma...
From the Journals
Tumor neoantigenicity metric improves prediction of response to immunotherapy
A new scoring system can predict response to immunotherapy in patients with melanoma, lung cancer, and kidney cancer.